Point72 Asia (Singapore)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Point72 Asia (Singapore)’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,095	Closed	-$37.5K	–	1612
2024 Q1	$37.5K	Buy	14,095 +11,895	+541%	+$29.4K	0.01%	858
2023 Q4	$5.21K	Buy	+2,200	New	+$3.89K	﹤0.01%	531

Point72 Asia (Singapore)'s KNTE Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 14,095 shares — an estimated $37.5K sold.

Point72 Asia (Singapore) first reported a position in KNTE in Q4 2023 and held it in 2 quarters. The position peaked at $37.5K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Point72 Asia (Singapore) reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Point72 Asia (Singapore) sold 14,095 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $37.5K.
Point72 Asia (Singapore) first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Point72 Asia (Singapore)'s Kinnate Biopharma Inc. Common Stock position peaked at $37.5K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.